key: cord-0863178-kkau59zp
authors: Guemes-Villahoz, Noemi; Burgos-Blasco, Barbara; Donate López, Juan; García-Feijoó, Julián
title: Retinal findings in COVID-19 patients with diabetes mellitus
date: 2020-08-29
journal: Diabetes Res Clin Pract
DOI: 10.1016/j.diabres.2020.108395
sha: a0bc6bc5b8547b98a2d77b81ca81cb18fa1b7ee9
doc_id: 863178
cord_uid: kkau59zp

nan

To the editor, We read with great interest the correspondence by Dr. Raony Considering these contradictory data, further research on COVID-19 retinal outcomes is warranted. We commend the authors on the interesting hypothesis. Whether SARS-CoV-2 infection may precipitate or exacerbate retinal lesions in patients with DM in the short-or long-term requires to be carefully evaluated.

COVID-19, SARS-Cov-2, CD147, Diabetes, Retina

No funding has been received for the preparation of this manuscript.

The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.

Retinal outcomes of COVID-19: Possible role of CD147 and cytokine storm in infected patients with diabetes mellitus

SARS-CoV-2 invades host cells via a novel route: CD147-spike protein. bioRxiv

Potential modes of COVID-19 transmission from human eye revealed by singlecell atlas

Basigin can be a therapeutic target to restore the retinal vascular barrier function in the mouse model of diabetic retinopathy

COVID-19 retinal microangiopathy as an in vivo biomarker of systemic vascular disease?

Retinal findings in patients with COVID-19

Concerns about the interpretation of OCT and fundus findings in COVID-19 patients in recent Lancet publication. Eye (Lond)

Optic nerve analysis in COVID-19 patients

SARS-CoV-2 RNA detection in tears and conjunctival secretions of COVID-19 patients with conjunctivitis

Detecting SARS-CoV-2 RNA in conjunctival secretions: is it a valuable diagnostic method of COVID-19